AlphaMark Advisors’s Bausch Health BHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-175
Closed -$1K 698
2024
Q2
$1K Buy
+175
New +$1.32K ﹤0.01% 693
2022
Q4
Sell
-1,159
Closed -$8K 597
2022
Q3
$8K Hold
1,159
﹤0.01% 441
2022
Q2
$10K Hold
1,159
﹤0.01% 392
2022
Q1
$26K Hold
1,159
0.01% 292
2021
Q4
$32K Hold
1,159
0.01% 281
2021
Q3
$32K Hold
1,159
0.01% 273
2021
Q2
$34K Hold
1,159
0.01% 267
2021
Q1
$37K Hold
1,159
0.01% 255
2020
Q4
$24K Hold
1,159
0.01% 279
2020
Q3
$18K Hold
1,159
0.01% 292
2020
Q2
$21K Hold
1,159
0.01% 277
2020
Q1
$18K Hold
1,159
0.01% 252
2019
Q4
$35K Hold
1,159
0.01% 223
2019
Q3
$25K Hold
1,159
0.01% 250
2019
Q2
$29K Buy
1,159
+231
+25% +$5.48K 0.01% 243
2019
Q1
$23K Buy
928
+10
+1% +$239 0.01% 245
2018
Q4
$17K Buy
918
+24
+3% +$571 0.01% 260
2018
Q3
$23K Buy
894
+108
+14% +$2.47K 0.01% 270
2018
Q2
$18K Hold
786
0.01% 303
2018
Q1
$13K Buy
786
+600
+323% +$11.2K 0.01% 327
2017
Q4
$4K Hold
186
﹤0.01% 428
2017
Q3
$3K Hold
186
﹤0.01% 445
2017
Q2
$3K Hold
186
﹤0.01% 457
2017
Q1
$2K Buy
+186
New +$2.56K ﹤0.01% 456
2016
Q2
Sell
-186
Closed -$5K 334
2016
Q1
$5K Buy
+186
New +$13.8K ﹤0.01% 256

Other funds holding BHC

AlphaMark Advisors's BHC Position: Q3 2024 in Review

AlphaMark Advisors sold out of Bausch Health (BHC) in Q3 2024, closing a stake of 175 shares — an estimated $1K sold.

AlphaMark Advisors first reported a position in BHC in Q1 2016 and held it in 25 quarters. The position peaked at $37K in Q1 2021. 211 funds tracked by Wall St. Rank hold BHC as of Q3 2024.

  • AlphaMark Advisors reported no remaining Bausch Health position as of Q3 2024 after selling out during the quarter.
  • AlphaMark Advisors sold 175 Bausch Health shares in Q3 2024, an estimated $1K.
  • AlphaMark Advisors first reported a position in Bausch Health in Q1 2016 and held it in 25 quarters.
  • AlphaMark Advisors's Bausch Health position peaked at $37K in Q1 2021.
  • 211 funds tracked by Wall St. Rank held Bausch Health as of Q3 2024.

Based on AlphaMark Advisors's 13F filing for Q3 2024, filed 16 Oct 2024.